 |
인쇄하기
취소
|
JW Holdings forges strategic tie-up with Japanese pharmaceutical firm
JW Holdings said Monday that it has forged a strategic alliance with a leading Japanese drug firm in an effort to strengthen its global competitiveness.
Under the contract with Sanwa Kagaku Kenkyusho, an affiliated company of Japan’s Suzuken Group, JW Holdings said both companies will co-develop and commercialize three incrementally modified drugs (IMDs).
Under the strategic alliance, JW ...
Under the contract with Sanwa Kagaku Kenkyusho, an affiliated company of Japan’s Suzuken Group, JW Holdings said both companies will co-develop and commercialize three incrementally modified drugs (IMDs).
Under the strategic alliance, JW ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.